Veryan (United Kingdom) a clinical-stage medical device company focused on a three dimensional vascular stent for peripheral vascular disease, closed a $5.4M series B financing. Participants include Seroba Kernal, Imperial Innovations, Oxford Capital Partners and NESTA.